107 related articles for article (PubMed ID: 27629131)
1. Assessment of clinicopathological features, evaluation of treatment, and prognosis of clear cell and serous papillary endometrial carcinoma.
Kulhan M; Kulhan G; Nayki U; Nayki C; Ulug P; Sipahi M; Yildirim Y
Ginekol Pol; 2016; 87(8):570-4. PubMed ID: 27629131
[TBL] [Abstract][Full Text] [Related]
2. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
3. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.
Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB
J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761
[TBL] [Abstract][Full Text] [Related]
5. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
Prueksaritanond N; Chantape W
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
[TBL] [Abstract][Full Text] [Related]
6. Nodal metastasis in endometrial cancer.
Willis G; Misas JE; Byrne W; Podczaski E
Eur J Gynaecol Oncol; 2011; 32(3):259-63. PubMed ID: 21797112
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy].
Xue DB; Ding LJ; Xia AL; Chen D; Xia HP; Teng XD; Xu ST; Zhang SJ; Ren XC
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):671-4. PubMed ID: 21176532
[TBL] [Abstract][Full Text] [Related]
8. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
9. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
10. [Impact of surgical resection extent on the prognosis of clinical stage I endometrial carcinoma].
Yan X; Gao YN; Jiang GQ; Gao M; An N
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):208-12. PubMed ID: 19615262
[TBL] [Abstract][Full Text] [Related]
11. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
Ren YL; Wang HY; Shen L; Yang WT
Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):817-21. PubMed ID: 17327111
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
[TBL] [Abstract][Full Text] [Related]
15. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley H; Lee RB; Gehrig PA; Zaino R
Gynecol Oncol; 2006 Feb; 100(2):349-54. PubMed ID: 16213007
[TBL] [Abstract][Full Text] [Related]
17. Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift.
Papadia A; Bellati F; Ditto A; Bogani G; Gasparri ML; Di Donato V; Martinelli F; Lorusso D; Benedetti-Panici P; Raspagliesi F
Ann Surg Oncol; 2015 Dec; 22(13):4204-10. PubMed ID: 25777095
[TBL] [Abstract][Full Text] [Related]
18. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in endometrial clear cell carcinoma.
Cetinkaya N; Selcuk İ; Ozdal B; Meydanli MM; Gungor T
Arch Gynecol Obstet; 2017 Jan; 295(1):189-195. PubMed ID: 27549092
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer.
Fotopoulou C; Richter R; Braicu IE; Schmidt SC; Neuhaus P; Lichtenegger W; Sehouli J
Ann Surg Oncol; 2011 Jan; 18(1):49-57. PubMed ID: 20697821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
